Physician profile

Larry D Wright

Family · Brownsville, TX

NPI 1033769765

$605.00

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$403.14

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $163.00 2021-2023
Genentech USA, INC. $125.08 2021-2022
Lilly USA, LLC $117.45 2023-2024 Mounjaro
Bayer Healthcare Pharmaceuticals INC. $57.56 2024
Amgen INC. $50.00 2023
Amarin Pharma, INC. $24.35 2021
Pfizer INC. $18.83 2024
Glaxosmithkline, LLC. $17.89 2022
Novo Nordisk INC $17.06 2023 Ozempic, Rybelsus
Exact Sciences Corporation $13.78 2024 Cologuard Collection Kit

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Larry D Wright

$605.00

in general payments reported 2019-2025

Years
2021-2024
Top company
Abbvie INC.

https://glasscript.com/doctor/10440036/larry-d-wright

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.